Praxis Biologics Inc said began initial public common stock offering 1,750,000 share 15.50 dlrs share .
The company said proceeds offering used fund product research development , including clinical testing .
It said money also used cover acquisition , construction equipment cost working capital .
The offering managed Shearson Lehman Bros Inc Merrill Lynch Capital Markets , company said .
Reuter & # 3 ; 